The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease
Open accessAbstract
Cognitive dysfunction is a common symptom of Parkinson's disease (PD) that causes significant morbidity and mortality. The severity of these symptoms ranges from minor executive symptoms to frank dementia involving multiple domains. In the present review, we will concentrate on the aspects of cognitive impairment associated with prefrontal dopaminergic dysfunction, seen in non-demented patients with PD. These symptoms include executive dysfunction and disorders of thought, such as hallucinations and psychosis. Such symptoms may go on to predict dementia related to PD, which involves amnestic dysfunction and is typically seen later in the disease. Cognitive symptoms are associated with dysfunction in cholinergic circuits, in addition to the abnormalities in the prefrontal dopaminergic system. These circuits can be carefully studied and evaluated in PD, and could be leveraged to treat difficult clinical problems related to cognitive symptoms of PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., Salmon, D. P., Lowe, J., Mirra, S. S., Byrne, E. J., et al. (1996) · Neurology · doi:10.1212/wnl.47.5.1113 · Cited by 3,960
Conflict monitoring and anterior cingulate cortex: an update
Botvinick, M. M., Cohen, J. D., & Carter, C. S. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.10.003 · Cited by 3,623
The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1988) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.51.6.745 · Cited by 3,481
Inverted-U–Shaped Dopamine Actions on Human Working Memory and Cognitive Control
Cools, R., & D'Esposito, M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.03.028 · Cited by 1,673
Modulation of memory fields by dopamine Dl receptors in prefrontal cortex
Williams, G. V., & Goldman-Rakic, P. S. (1995) · Nature · doi:10.1038/376572a0 · Cited by 1,593
Cognitive profile of patients with newly diagnosed Parkinson disease
Muslimović, D., Post, B., Speelman, J. D., & Schmand, B. (2005) · Neurology · doi:10.1212/01.wnl.0000180516.69442.95 · Cited by 1,007 · cited 1×
“Cognitive dysfunction is common in PD (Muslimovic et al., 2005).”
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
Cools, R. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.12.1136 · Cited by 906
‘Frontal' cognitive function in patients with Parkinson's disease ‘on' and ‘off' levodopa
GOTHAM, A. M., BROWN, R. G., & MARSDEN, C. D. (1988) · Brain · doi:10.1093/brain/111.2.299 · Cited by 835
Research works printed but not linked: 250
- Dopaminergic, 2006, Cools modulation of cognitive function - implications for treatment in Parkinson s disease, Neurosci Biobehav Rev, 30, 1, 10.1016/j.neubiorev.2005.03.024 · DOI · Paper page
- Voon, 2011, Impulse control disorders in Parkinson disease : a multicenter case control study, Neurol, 69
- Balzer, 2011, s disease dementia a longitudinal study, Parkinson Neuroepidemiology, 37
- Voon, 2006, de and Prospective prevalence of pathologic gambling and medication association in Parkinson disease, Neurology, 1750, 10.1212/01.wnl.0000218206.20920.4d · DOI · Paper page
- Rowan, 2007, Effects of donepezil on central processing speed and attentional measures in Parkinson s disease with dementia and dementia with Lewy bodies, Geriatr Cogn Disord, 23, 161, 10.1159/000098335 · DOI
- Huang, 2007, Carbon Metabolic brain networks associated with cognitive function in Parkinson s disease, Neuroimage, 714, 10.1016/j.neuroimage.2006.09.003 · DOI · Paper page
- Müller, 2006, The DONPAD - study treatment of dementia in patients with Parkinson s disease with donepezil, Neural Transm, 71, 27
- Pontone, 2006, Clinical features associated with impulse control disorders in Parkinson disease, Neurology, 67
- Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson s disease : a clinico - pathological study of cases, Neurol Psychiatr, 181, 10.1136/jnnp.55.3.181 · DOI · Paper page
- Bohnen, 2003, Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease : an in vivo positron emission tomographic study, Arch, 1745
- Seamans, 1998, receptor modulation of hippocampal - prefrontal cortical circuits integrating spatial memory with executive functions in the rat, Neurosci, 18, 1, 10.1523/JNEUROSCI.18-04-01613.1998 · DOI · Paper page
- Scatton, 1983, Reduction of cortical dopamine noradrenaline serotonin and their metabolites in Parkinson s disease, Brain Res, 275
- Jellinger, 2009, critical evaluation of current staging of α - synuclein pathology in Lewy body disorders, Biochim Biophys Acta, 730, 10.1016/j.bbadis.2008.07.006 · DOI · Paper page
- Kim, 2012, Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease, Neurology, 1323, 10.1212/WNL.0b013e31826c1acd · DOI
- Dalrymple, 2010, The well - suited screen for cognitive impairment in Parkinson disease, Neurology, 1717, 10.1212/WNL.0b013e3181fc29c9 · DOI · Paper page
- Pascual, 2008, and executive performance in Parkinson s disease : a randomized study, Int Soc, 14, 832
- Dias, 2006, Changing plans : neural correlates of executive control in monkey and human frontal, cortex Brain Res, 174
- Seong, 2012, receptor modulation of action potential firing in a subpopulation of layer pyramidal neurons in the prefrontal, cortex Neurosci, 1
- Jellinger, 2009, critical evaluation of current staging of α - synuclein pathology in Lewy body disorders, Biochim Biophys Acta, 730, 10.1016/j.bbadis.2008.07.006 · DOI · Paper page
- Okubo, 1997, Decreased prefrontal dopamine receptors in schizophrenia revealed by PET, Nature, 1
- Emre, 2007, Clinical diagnostic criteria for dementia associated with Parkinson s disease quiz, Soc, 22, 1689
- Morrison, 2004, Effects of levodopa on cognitive functioning in moderate - to - severe Parkinson s disease, Neural Transm, 111
- Dubois, 1987, - dependent cognitive deficits in Parkinson s disease, Ann Neurol, 22
- Bohnen, 2003, Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease : an in vivo positron emission tomographic study, Arch, 1745
- Gaspar, 1995, receptor gene expression in the rat frontal cellular localization in different classes of efferent neurons, cortex Eur J Neurosci, 1050, 10.1111/j.1460-9568.1995.tb01092.x · DOI · Paper page
- Gibb, 1988, The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson s disease, Neurol Psychiatr, 745, 10.1136/jnnp.51.6.745 · DOI · Paper page
- Aarsland, 2010, The epidemiology of dementia associated with Parkinson s disease, Brain Pathology, 20, 633, 10.1111/j.1750-3639.2009.00369.x · DOI · Paper page
- Weinberger, 1986, Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia Regional cerebral blood flow evidence, Arch Gen Psychiatry, 114, 10.1001/archpsyc.1986.01800020020004 · DOI · Paper page
- Meyer, 2009, Reduced α β - nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease, Arch Gen Psychiatry, 4, 866, 10.1001/archgenpsychiatry.2009.106 · DOI · Paper page
- Aarsland, 2002, Donepezil for cognitive impairment in Parkinson s disease : a randomised controlled study, Neurol Psychiatr, 708, 10.1136/jnnp.72.6.708 · DOI · Paper page
- Goldman, 1998, The cortical dopamine system role in memory, cognition Adv Pharmacol, 707
- Emre, 2007, Clinical diagnostic criteria for dementia associated with Parkinson s disease quiz, Soc, 22, 1689
- Nikiforuk, 2012, receptor modulation of set shifting : the role of stress exposure, Pharmacol, 23, 1
- Seamans, 1998, receptor modulation of hippocampal - prefrontal cortical circuits integrating spatial memory with executive functions in the rat, Neurosci, 18, 1, 10.1523/JNEUROSCI.18-04-01613.1998 · DOI · Paper page
- Javoy, 1981, Microtopography of tyrosine hydroxylase glutamic acid decarboxylase and choline acetyltransferase in the substantia nigra and ventral tegmental area of control and Parkinsonian brains, Neurochem, 37
- Arendt, 1983, Loss of neurons in the nucleus basalis of Meynert in Alzheimer s disease paralysis agitans and Korsakoff s Disease, Acta Neuropathol, 61
- Narayanan, 2012, dopamine signaling is required for temporal control, Proc Natl Acad Sci USA, 1
- Coull, 2011, neurochemical substrates of timing, Neuropsychopharmacology, 36, 10.1038/npp.2010.113 · DOI · Paper page
- Okubo, 1997, Decreased prefrontal dopamine receptors in schizophrenia revealed by PET, Nature, 1
- Miller, 2001, An integrative theory of prefrontal function, cortex Annu Rev Neurosci, 24, 167, 10.1146/annurev.neuro.24.1.167 · DOI · Paper page
- Candy, 1983, Pathological changes in the nucleus of Meynert in Alzheimer s and Parkinson s diseases, Neurol Sci, 59
- Kehm, 2012, a Pathological α - Synuclein Transmission Initiates Parkinson - like Neurodegeneration in Nontransgenic Mice, Science, 338
- Williams, 2008, Attentional control in Parkinson s disease is dependent on COMT val genotype, Brain, 158
- Garell, 2012, Functional connection between posterior superior temporal gyrus and ventrolateral prefrontal cortex in human Epub ahead of print, Cortex
- Müller, 2001, Delay of simple reaction time after levodopa intake, Clin Neurophysiol, 112
- Uc, 2009, Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort, Neurology, 73
- Wolk, 1992, Clozapine treatment of psychosis in Parkinson s disease : a report of five consecutive cases, Clin Psychiatry, 53
- Voon, 2006, de and a Prevalence of repetitive and reward - seeking behaviors in Parkinson disease, Neurology, 67
- Dubois, 1997, Cognitive deficits in Parkinson s disease, Neurol, 244
- Jahanshahi, 2010, Dopaminergic modulation of striato - frontal connectivity during motor timing in Parkinson s disease, Brain, 133
- Kempster, 2010, Relationships between age and late progression of Parkinson s disease : a clinico - pathological study, Brain, 133
- Crizzle, 2012, Parkinson disease driving an evidence based, review Neurology, 2067, 10.1212/WNL.0b013e3182749e95 · DOI
- Emre, 2004, for dementia associated with Parkinson s disease, Engl J Med, 351
- Kehm, 2012, Intracerebral inoculation of pathological α - synuclein initiates a rapidly progressive neurodegenerative α - synucleinopathy in mice, Exp Med, 209
- Jahanshahi, 2010, Dopaminergic modulation of striato - frontal connectivity during motor timing in Parkinson s disease, Brain, 133
- Levy, 2002, The association of incident dementia with mortality in, Neurology, 59
- Gaspar, 1995, receptor gene expression in the rat frontal cellular localization in different classes of efferent neurons, cortex Eur J Neurosci, 1050, 10.1111/j.1460-9568.1995.tb01092.x · DOI · Paper page
- Lange, 1992, dopa withdrawal in Parkinson s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction, Psychopharmacology, 107
- Müller, 2006, The DONPAD - study treatment of dementia in patients with Parkinson s disease with donepezil, Neural Transm, 71, 27
- Pontone, 2006, Clinical features associated with impulse control disorders in Parkinson disease, Neurology, 67
- Narayanan, 2009, Delay activity in rodent frontal cortex during a simple reaction time task, Neurophysiol, 101
- Litvan, 2011, Task Force on mild cognitive impairment in Parkinson s disease critical of, review, 26, 1814
- Fabbrini, 2002, Donepezil in the treatment of hallucinations and delusions in Parkinson s disease, Sci, 23
- Cools, 2002, Dopaminergic modulation of high - level cognition in Parkinson s disease : the role of the prefrontal cortex revealed by PET, Brain, 125
- Litvan, 2011, Task Force on mild cognitive impairment in Parkinson s disease critical of, review, 26, 1814
- Aarsland, 2010, The epidemiology of dementia associated with Parkinson s disease, Brain Pathology, 20, 633, 10.1111/j.1750-3639.2009.00369.x · DOI · Paper page
- Swanberg, 2004, Executive dysfunction in Alzheimer disease, Arch, 556
- Fuster, 2008, The th ed New Academic, Prefrontal Cortex
- Lippa, 2007, boundary issues diagnosis treatment molecular, pathology biomarkers Neurology, 812
- Polito, 2012, Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson s disease, Aging, 206
- Bédard, 1999, Acute and long - term administration of anticholinergics in Parkinson s disease : specific effects on the subcortico - frontal syndrome, Brain, 289
- Baddeley, 1998, The central executive a concept and some misconceptions, Int Neuropsychol Soc, 523, 10.1017/S135561779800513X · DOI · Paper page
- Litvan, 1991, Differential memory and executive functions in demented patients with Parkinson s and Alzheimer s disease, Neurol Psychiatry, 54, 25, 10.1136/jnnp.54.1.25 · DOI
- Meyer, 2009, Reduced α β - nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease, Arch Gen Psychiatry, 4, 866, 10.1001/archgenpsychiatry.2009.106 · DOI · Paper page
- Voon, 2006, de and a Prevalence of repetitive and reward - seeking behaviors in Parkinson disease, Neurology, 67
- Westerink, 1998, The pharmacology of mesocortical dopamine neurons : a dual - probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain, Pharmacol Exp Ther, 285
- Gilman, 2010, Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes, Neurology, 1416, 10.1212/WNL.0b013e3181dc1a55 · DOI · Paper page
- Hobson, 2004, and incidence of dementia in a cohort of older subjects with Parkinson s disease in the United Kingdom, Risk, 19, 1043
- Kaasinen, 2001, Rinne Increased frontal fluorodopa uptake in early Parkinson s disease : sex differences in the prefrontal, cortex Brain, 18, 124
- Kehm, 2012, a Pathological α - Synuclein Transmission Initiates Parkinson - like Neurodegeneration in Nontransgenic Mice, Science, 338
- Dubois, 1997, Cognitive deficits in Parkinson s disease, Neurol, 244
- Narayanan, 2012, dopamine signaling is required for temporal control, Proc Natl Acad Sci USA, 1
- Compta, 2011, de and Alzheimer - type pathologies in Parkinson s disease dementia : which is more important, Brain, 134
- Foltynie, 2004, a The cognitive ability of an incident cohort of Parkinson s patients in the UK The CamPaIGN study, Brain, 127
- Williams, 2009, The distinct cognitive syndromes of Parkinson s disease year follow - up of the CamPaIGN cohort, Brain, 132
- Jellinger, 2011, deposition and non - motor symptoms in Parkinson disease, Neurol Sci, 310
- Floresco, 2001, Delay - dependent modulation of memory retrieval by infusion of a dopamine agonist into the rat medial prefrontal, cortex Neurosci, 1
- Floresco, 2001, Delay - dependent modulation of memory retrieval by infusion of a dopamine agonist into the rat medial prefrontal, cortex Neurosci, 1
- Rowan, 2007, Effects of donepezil on central processing speed and attentional measures in Parkinson s disease with dementia and dementia with Lewy bodies, Geriatr Cogn Disord, 23, 161, 10.1159/000098335 · DOI
- Rizzo, 2005, Visual dysfunction in Parkinson disease without dementia, Neurology, 1907
- Burton, 2004, Cerebral atrophy in Parkinson s disease with and without dementia : a comparison with Alzheimer s disease dementia with Lewy bodies and controls, Brain, 127
- Miller, 2001, An integrative theory of prefrontal function, cortex Annu Rev Neurosci, 24, 167, 10.1146/annurev.neuro.24.1.167 · DOI · Paper page
- Vrieze, 2013, Measuring extrastriatal dopamine release during a reward learning task, Hum Brain Mapp, 575, 10.1002/hbm.21456 · DOI
- Crizzle, 2012, Parkinson disease driving an evidence based, review Neurology, 2067, 10.1212/WNL.0b013e3182749e95 · DOI
- Lange, 1992, dopa withdrawal in Parkinson s disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction, Psychopharmacology, 107
- Claassen, 2010, Tippmann sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century, Neurology, 494, 10.1212/WNL.0b013e3181ec7fac · DOI · Paper page
- Fujita, 2006, Widespread decrease of nicotinic acetylcholine receptors in Parkinson s disease, Ann Neurol, 59
- Jellinger, 1999, Post mortem studies in Parkinson s disease is it possible to detect brain areas for specific symptoms, Neural Transm, 1
- Kieburtz, 1994, The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson s disease Parkinson Study Group, Neurology, 1756, 10.1212/WNL.44.9.1756 · DOI
- Schmitt, 2010, Efficacy of rivastigmine on executive function in patients with Parkinson s disease dementia, Neurosci Ther, 16, 330, 10.1111/j.1755-5949.2010.00182.x · DOI
- Burack, 2010, In vivo amyloid imaging in autopsy - confirmed Parkinson disease with dementia, Neurology, 74
- Dirnberger, 2005, Executive dysfunction in Parkinson s disease is associated with altered pallidal - frontal processing, Neuroimage, 25, 588, 10.1016/j.neuroimage.2004.11.023 · DOI
- Cooper, 1991, Cognitive impairment in early untreated Parkinson s disease and its relationship to motor disability, Brain, 114
- Kempster, 2010, Relationships between age and late progression of Parkinson s disease : a clinico - pathological study, Brain, 133
- Wurtman, 2012, medicine strategies for managing patients with Parkinsonism and cognitive deficits Metab Clin Exp Available at http www ncbi nlm nih gov pubmed Accessed September, Personalized, 28
- Morrison, 2004, Effects of levodopa on cognitive functioning in moderate - to - severe Parkinson s disease, Neural Transm, 111
- Javoy, 1980, Is the mesocortical dopaminergic system involved in Parkinson disease, Neurology, 30, 1326, 10.1212/WNL.30.12.1326 · DOI · Paper page
- Sawamoto, 2008, Cognitive deficits and striato - frontal dopamine release in Parkinson s disease, Brain, 131
- Fabbrini, 2002, Donepezil in the treatment of hallucinations and delusions in Parkinson s disease, Sci, 23
- Jellinger, 1999, Post mortem studies in Parkinson s disease is it possible to detect brain areas for specific symptoms, Neural Transm, 1
- Williams, 2008, Attentional control in Parkinson s disease is dependent on COMT val genotype, Brain, 158
- Wurtman, 2012, medicine strategies for managing patients with Parkinsonism and cognitive deficits Metab Clin Exp Available at http www ncbi nlm nih gov pubmed Accessed September, Personalized, 28
- Asaad, 1998, Neural activity in the primate prefrontal cortex during associative learning, Neuron, 21, 1399, 10.1016/S0896-6273(00)80658-3 · DOI · Paper page
- Litvan, 1991, Differential memory and executive functions in demented patients with Parkinson s and Alzheimer s disease, Neurol Psychiatry, 54, 25, 10.1136/jnnp.54.1.25 · DOI
- Aarsland, 2005, systematic review of prevalence studies of dementia in Parkinson s disease, 20, 1255
- Dubois, 1987, - dependent cognitive deficits in Parkinson s disease, Ann Neurol, 22
- Scatton, 1983, Reduction of cortical dopamine noradrenaline serotonin and their metabolites in Parkinson s disease, Brain Res, 275
- Aarsland, 2005, systematic review of prevalence studies of dementia in Parkinson s disease, 20, 1255
- Dias, 2006, Changing plans : neural correlates of executive control in monkey and human frontal, cortex Brain Res, 174
- Elgh, 2009, Cognitive function in early Parkinson s disease : a population - based study, Eur J Neurol, 16, 1278, 10.1111/j.1468-1331.2009.02707.x · DOI · Paper page
- Narayanan, 2006, - down control of motor cortex ensembles by dorsomedial prefrontal, Top cortex Neuron, 921
- Voon, 2011, Impulse control disorders in Parkinson disease : a multicenter case control study, Neurol, 69
- Williams, 2007, of cognitive dysfunction in an incident Parkinson s disease cohort, Evolution Brain, 130
- Forsaa, 2010, a What predicts mortality in Parkinson disease a prospective population - based long - term study, Neurology, 1270, 10.1212/WNL.0b013e3181f61311 · DOI · Paper page
- Müller, 2001, Delay of simple reaction time after levodopa intake, Clin Neurophysiol, 112
- Graybiel, 1994, The basal ganglia and adaptive motor control, Science, 265
- Gilman, 2010, Cerebral cortical and subcortical cholinergic deficits in parkinsonian syndromes, Neurology, 1416, 10.1212/WNL.0b013e3181dc1a55 · DOI · Paper page
- Asaad, 1998, Neural activity in the primate prefrontal cortex during associative learning, Neuron, 21, 1399, 10.1016/S0896-6273(00)80658-3 · DOI · Paper page
- Wu, 2012, The catechol methyltransferase Met polymorphism modulates fronto - cortical dopamine turnover in early Parkinson s disease : a PET study, Brain, 158
- Pascual, 2008, and executive performance in Parkinson s disease : a randomized study, Int Soc, 14, 832
- Braver, 1999, control in schizophrenia : a computational model of dopamine and prefrontal function, Cognition Biol Psychiatry, 312, 10.1016/S0006-3223(99)00116-X · DOI · Paper page
- Williams, 2007, of cognitive dysfunction in an incident Parkinson s disease cohort, Evolution Brain, 130
- Ávila, 2011, Impulsive and compulsive behaviors in Parkinson s disease : a one - year follow - up study, Neurol Sci, 310
- Weinberger, 1986, Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia Regional cerebral blood flow evidence, Arch Gen Psychiatry, 114, 10.1001/archpsyc.1986.01800020020004 · DOI · Paper page
- Dopaminergic, 2006, Cools modulation of cognitive function - implications for treatment in Parkinson s disease, Neurosci Biobehav Rev, 30, 1, 10.1016/j.neubiorev.2005.03.024 · DOI · Paper page
- Huang, 2007, Carbon Metabolic brain networks associated with cognitive function in Parkinson s disease, Neuroimage, 714, 10.1016/j.neuroimage.2006.09.003 · DOI · Paper page
- Ekman, 2012, Functional brain activity and presynaptic dopamine uptake in patients with Parkinson s disease and mild cognitive impairment : a cross - sectional study, Lancet Neurol, 11, 679, 10.1016/S1474-4422(12)70138-2 · DOI · Paper page
- Graybiel, 1994, The basal ganglia and adaptive motor control, Science, 265
- Esposito, 2011, Cools Inverted shaped dopamine actions on human working memory and cognitive control, Biol Psychiatry, 69
- Fuster, 2008, The th ed New Academic, Prefrontal Cortex
- Candy, 1983, Pathological changes in the nucleus of Meynert in Alzheimer s and Parkinson s diseases, Neurol Sci, 59
- Coull, 2011, neurochemical substrates of timing, Neuropsychopharmacology, 36, 10.1038/npp.2010.113 · DOI · Paper page
- Aarsland, 2000, Predictors of nursing home placement in Parkinson s disease : a population - based prospective study, Am Geriatr Soc, 938, 10.1111/j.1532-5415.2000.tb06891.x · DOI · Paper page
- Aarsland, 2011, Mild cognitive impairment in Parkinson s disease, Curr Neurol Neurosci Rep, 11, 371, 10.1007/s11910-011-0203-1 · DOI · Paper page
- Jellinger, 2011, deposition and non - motor symptoms in Parkinson disease, Neurol Sci, 310
- Seong, 2012, receptor modulation of action potential firing in a subpopulation of layer pyramidal neurons in the prefrontal, cortex Neurosci, 1
- Kaasinen, 2001, Rinne Increased frontal fluorodopa uptake in early Parkinson s disease : sex differences in the prefrontal, cortex Brain, 18, 124
- Voon, 2006, de and Prospective prevalence of pathologic gambling and medication association in Parkinson disease, Neurology, 1750, 10.1212/01.wnl.0000218206.20920.4d · DOI · Paper page
- Fonnum, 1966, Is choline acetyltransferase present in synaptic vesicles, Biochem Pharmacol, 15, 1641, 10.1016/0006-2952(66)90216-4 · doi:10.1016/0006-2952(66)90216-4
- Vrieze, 2013, Measuring extrastriatal dopamine release during a reward learning task, Hum Brain Mapp, 575, 10.1002/hbm.21456 · DOI
- Westerink, 1998, The pharmacology of mesocortical dopamine neurons : a dual - probe microdialysis study in the ventral tegmental area and prefrontal cortex of the rat brain, Pharmacol Exp Ther, 285
- Castner, 2007, Tuning the engine of a focus on receptor interactions in prefrontal, cognition cortex Brain, 1
- Perry, 1985, Cholinergic correlates of cognitive impairment in Parkinson s disease : comparisons with Alzheimer s disease, Neurol Psychiatr, 413, 10.1136/jnnp.48.5.413 · DOI · Paper page
- Rakshi, 1999, Frontal midbrain and striatal dopaminergic function in early and advanced Parkinson s disease dopa - PET study, Brain, 18, 122
- Irwin, 2012, substrates of Parkinson disease dementia, Neurol, 587
- Elgh, 2009, Cognitive function in early Parkinson s disease : a population - based study, Eur J Neurol, 16, 1278, 10.1111/j.1468-1331.2009.02707.x · DOI · Paper page
- Compta, 2011, de and Alzheimer - type pathologies in Parkinson s disease dementia : which is more important, Brain, 134
- Fahn, 2004, the progression of Parkinson s disease, Engl J Med, 351
- Schmitt, 2010, Efficacy of rivastigmine on executive function in patients with Parkinson s disease dementia, Neurosci Ther, 16, 330, 10.1111/j.1755-5949.2010.00182.x · DOI
- Dunning, 2012, Can Parkinson s disease pathology be propagated from one neuron to another, Prog Neurobiol, 205, 10.1016/j.pneurobio.2011.11.003 · DOI
- Castner, 2007, Tuning the engine of a focus on receptor interactions in prefrontal, cognition cortex Brain, 1
- Sawamoto, 2008, Cognitive deficits and striato - frontal dopamine release in Parkinson s disease, Brain, 131
- Burack, 2010, In vivo amyloid imaging in autopsy - confirmed Parkinson disease with dementia, Neurology, 74
- Rizzo, 2005, Visual dysfunction in Parkinson disease without dementia, Neurology, 1907
- Factor, 2003, Longitudinal outcome of Parkinson s disease patients with psychosis, Neurology, 1756, 10.1212/01.WNL.0000068010.82167.CF · DOI · Paper page
- Swanberg, 2004, Executive dysfunction in Alzheimer disease, Arch, 556
- Cooper, 1991, Cognitive impairment in early untreated Parkinson s disease and its relationship to motor disability, Brain, 114
- Cools, 2002, Dopaminergic modulation of high - level cognition in Parkinson s disease : the role of the prefrontal cortex revealed by PET, Brain, 125
- Dubois, 1995, Do cognitive changes of Parkinson s disease result from dopamine depletion, Neural Transm, 45, 27
- Dunning, 2012, Can Parkinson s disease pathology be propagated from one neuron to another, Prog Neurobiol, 205, 10.1016/j.pneurobio.2011.11.003 · DOI
- Phillips, 2004, Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task, Neurosci, 24, 547, 10.1523/JNEUROSCI.4653-03.2004 · DOI · Paper page
- Gotham, 1988, Frontal cognitive function in patients with Parkinson s disease on and off levodopa, Brain, 111
- Phillips, 2004, Magnitude of dopamine release in medial prefrontal cortex predicts accuracy of memory on a delayed response task, Neurosci, 24, 547, 10.1523/JNEUROSCI.4653-03.2004 · DOI · Paper page
- Garell, 2012, Functional connection between posterior superior temporal gyrus and ventrolateral prefrontal cortex in human Epub ahead of print, Cortex
- Kotzbauer, 2012, Perlmutter Pathologic accumulation of α - synuclein and Aβ in Parkinson disease patients with dementia, Arch, 10, 1
- Balzer, 2011, s disease dementia a longitudinal study, Parkinson Neuroepidemiology, 37
- Arendt, 1983, Loss of neurons in the nucleus basalis of Meynert in Alzheimer s disease paralysis agitans and Korsakoff s Disease, Acta Neuropathol, 61
- McKeith, 1996, Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies report of the consortium on DLB international workshop, Neurology, 1113, 10.1212/WNL.47.5.1113 · DOI · Paper page
- Bosboom, 2003, The role of acetylcholine and dopamine in dementia and psychosis in Parkinson s disease, Neural Transm, 185
- Hughes, 1992, Accuracy of clinical diagnosis of idiopathic Parkinson s disease : a clinico - pathological study of cases, Neurol Psychiatr, 181, 10.1136/jnnp.55.3.181 · DOI · Paper page
- Williams, 2009, The distinct cognitive syndromes of Parkinson s disease year follow - up of the CamPaIGN cohort, Brain, 132
- Fahn, 2004, the progression of Parkinson s disease, Engl J Med, 351
- Kim, 2012, Association of cognitive dysfunction with neurocirculatory abnormalities in early Parkinson disease, Neurology, 1323, 10.1212/WNL.0b013e31826c1acd · DOI
- Javoy, 1980, Is the mesocortical dopaminergic system involved in Parkinson disease, Neurology, 30, 1326, 10.1212/WNL.30.12.1326 · DOI · Paper page
- Dubois, 1995, Do cognitive changes of Parkinson s disease result from dopamine depletion, Neural Transm, 45, 27
- Ekman, 2012, Functional brain activity and presynaptic dopamine uptake in patients with Parkinson s disease and mild cognitive impairment : a cross - sectional study, Lancet Neurol, 11, 679, 10.1016/S1474-4422(12)70138-2 · DOI · Paper page
- Wolk, 1992, Clozapine treatment of psychosis in Parkinson s disease : a report of five consecutive cases, Clin Psychiatry, 53
- Kotzbauer, 2012, Perlmutter Pathologic accumulation of α - synuclein and Aβ in Parkinson disease patients with dementia, Arch, 10, 1
- Polito, 2012, Interaction of caudate dopamine depletion and brain metabolic changes with cognitive dysfunction in early Parkinson s disease, Aging, 206
- Burton, 2004, Cerebral atrophy in Parkinson s disease with and without dementia : a comparison with Alzheimer s disease dementia with Lewy bodies and controls, Brain, 127
- Ávila, 2011, Impulsive and compulsive behaviors in Parkinson s disease : a one - year follow - up study, Neurol Sci, 310
- Muslimovic, 2005, Post Speelman Schmand Cognitive profile of patients with newly diagnosed Parkinson disease, Neurology, 1239, 10.1212/01.wnl.0000180516.69442.95 · DOI · Paper page
- Arnsten, 2005, of executive functions : catecholamine influences on prefrontal cortical functions, Neurobiology Biol Psychiatry, 1377, 10.1016/j.biopsych.2004.08.019 · DOI · Paper page
- Weintraub, 2006, Association of dopamine agonist use with impulse control disorders in Parkinson disease, Arch, 969
- Bohnen, 2006, Cognitive correlates of cortical cholinergic denervation in Parkinson s disease and parkinsonian dementia, Neurol, 253
- Braver, 1999, control in schizophrenia : a computational model of dopamine and prefrontal function, Cognition Biol Psychiatry, 312, 10.1016/S0006-3223(99)00116-X · DOI · Paper page
- Williams, 2006, Cognitive deficits and psychosis in Parkinson s disease a review of pathophysiology and therapeutic options, CNS Drugs, 20, 477, 10.2165/00023210-200620060-00004 · DOI · Paper page
- Lennox, 1992, body dementia, Clin, 1
- Williams, 1995, Modulation of memory fields by dopamine receptors in prefrontal, cortex Nature, 1
- Dymecki, 1996, Changes in dopaminergic neurons of the mesocorticolimbic system in Parkinson s disease, Folia Neuropathol, 102
200 of 250 shown
Cited by
The neurobiological basis of cognitive impairment in Parkinson's disease
Halliday, G. M., Leverenz, J. B., Schneider, J. S., & Adler, C. H. (2014) · Movement Disorders · doi:10.1002/mds.25857 · Cited by 366
Lack of Neuronal IFN-β-IFNAR Causes Lewy Body- and Parkinson’s Disease-like Dementia
Ejlerskov, P., Hultberg, J. G., Wang, J., Carlsson, R., Ambjørn, M., Kuss, M., Liu, Y., Porcu, G., Kolkova, K., Friis Rundsten, C., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.069 · Cited by 211
Neural basis of bilingual language control
Calabria, M., Costa, A., Green, D. W., & Abutalebi, J. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13879 · Cited by 190
Sundaram, S., Hughes, R. L., Peterson, E., Müller-Oehring, E. M., Brontë-Stewart, H. M., Poston, K. L., Faerman, A., Bhowmick, C., & Schulte, T. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.05.016 · Cited by 152
Dopamine’s Actions in Primate Prefrontal Cortex: Challenges for Treating Cognitive Disorders
Arnsten, A. F. T., Wang, M., & Paspalas, C. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010512 · Cited by 149
Metadata
- Authors
- Narayanan, N. S., Rodnitzky, R. L., & Uc, E. Y.
- Venue
- Reviews in the Neurosciences
- Publisher
- Walter de Gruyter GmbH
- Published
- 2013-01-01
- Volume
- 24
- Issue
- 3
- Pages
- 267-78
- ISSN
- 0334-1763 (ISSN-L)
- 2191-0200
- OpenAlex
- W2024403313
- Cited by
- 176
- References
- 24
- FWCI
- 8.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease. https://app.cochat.ai/papers/10.1515/revneuro-2013-0004
- The paper
- Narayanan, N. S., Rodnitzky, R. L., & Uc, E. Y. (2013). Prefrontal dopamine signaling and cognitive symptoms of Parkinson’s disease. Reviews in the Neurosciences. https://doi.org/10.1515/revneuro-2013-0004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.